HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kirby, H. Articles by Bell, A. Search for Related Content PubMed PubMed Citation Articles by Kirby, H. Articles by Bell, A. Agricola Articles by Kirby, H. Articles by Bell, A.

The activity of the Epstein–Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors

CRC Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham B15 2TA, UK¹

Author for correspondence: Andrew Bell. Fax +44 121 414 4486. e-mail a.i.bell{at}bham.ac.uk

The programme of Epstein–Barr virus (EBV) gene expression that leads to virus-induced growth transformation of resting B lymphocytes is initiated through activation of the BamHI W promoter, Wp. The factors regulating Wp, and the basis of its preferential activity in B cells, remain poorly understood. Previous work has identified a B cell-specific enhancer region which is critical for Wp function and which contains three binding sites for cellular factors. Here we focus on one of these sites and show, using bandshift assays, that it interacts with three members of the CREB/ATF family of cell transcription factors, CREB1, ATF1 and ATFa. A mutation which abrogates the binding of these factors reduces Wp reporter activity specifically in B cell lines, whereas a mutation which converts the site to a consensus CREB-binding sequence maintains wild-type promoter function. Furthermore Wp activity in B cell, but not in non-B cell, lines could be inhibited by cotransfection of expression plasmids expressing dominant negative forms of CREB1 and ATF1. Increasing the basal activity of CREB/ATF proteins in cells by treatment with protein kinase A or protein kinase C agonists led to small increases in Wp activity in B cell lines, but did not restore promoter activity in non-B cell lines up to B cell levels. We conclude that CREB/ATF factors are important activators of Wp in a B cell environment but require additional B cell-specific factors in order to mediate their effects.

This article has been cited by other articles:

				R. Tierney, J. Nagra, I. Hutchings, C. Shannon-Lowe, M. Altmann, W. Hammerschmidt, A. Rickinson, and A. Bell Epstein-Barr Virus Exploits BSAP/Pax5 To Achieve the B-Cell Specificity of Its Growth-Transforming Program J. Virol., September 15, 2007; 81(18): 10092 - 10100. [Abstract] [Full Text] [PDF]

				I. A. Hutchings, R. J. Tierney, G. L. Kelly, J. Stylianou, A. B. Rickinson, and A. I. Bell Methylation Status of theEpstein-Barr Virus (EBV) BamHI W Latent Cycle Promoter and Promoter Activity: Analysis with Novel EBV-Positive Burkitt and Lymphoblastoid Cell Lines J. Virol., November 1, 2006; 80(21): 10700 - 10711. [Abstract] [Full Text] [PDF]

				M. Altmann, D. Pich, R. Ruiss, J. Wang, B. Sugden, and W. Hammerschmidt Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes PNAS, September 19, 2006; 103(38): 14188 - 14193. [Abstract] [Full Text] [PDF]

				M. Yoshioka, H. Kikuta, N. Ishiguro, X. Ma, and K. Kobayashi Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection J. Gen. Virol., May 1, 2003; 84(5): 1133 - 1140. [Abstract] [Full Text] [PDF]

				N. van der Stoep, E. Quinten, and P. J. van den Elsen Transcriptional Regulation of the MHC Class II Trans-Activator (CIITA) Promoter III: Identification of a Novel Regulatory Region in the 5'-Untranslated Region and an Important Role for cAMP-Responsive Element Binding Protein 1 and Activating Transcription Factor-1 in CIITA-Promoter III Transcriptional Activation in B Lymphocytes J. Immunol., November 1, 2002; 169(9): 5061 - 5071. [Abstract] [Full Text] [PDF]

				L. I. Yoo, J. Woloszynek, S. Templeton, and S. H. Speck Deletion of Epstein-Barr Virus Regulatory Sequences Upstream of the EBNA Gene Promoter Wp1 Is Unfavorable for B-Cell Immortalization J. Virol., October 11, 2002; 76(22): 11763 - 11769. [Abstract] [Full Text] [PDF]

				I. Han, Y. Xue, S. Harada, S. Orstavik, B. Skalhegg, and E. Kieff Protein Kinase A Associates with HA95 and Affects Transcriptional Coactivation by Epstein-Barr Virus Nuclear Proteins Mol. Cell. Biol., April 1, 2002; 22(7): 2136 - 2146. [Abstract] [Full Text] [PDF]

				R. Tierney, H. Kirby, J. Nagra, A. Rickinson, and A. Bell The Epstein-Barr Virus Promoter Initiating B-Cell Transformation Is Activated by RFX Proteins and the B-Cell-Specific Activator Protein BSAP/Pax5 J. Virol., November 15, 2000; 74(22): 10458 - 10467. [Abstract] [Full Text]

				R. J. Tierney, H. E. Kirby, J. K. Nagra, J. Desmond, A. I. Bell, and A. B. Rickinson Methylation of Transcription Factor Binding Sites in the Epstein-Barr Virus Latent Cycle Promoter Wp Coincides with Promoter Down-Regulation during Virus-Induced B-Cell Transformation J. Virol., November 15, 2000; 74(22): 10468 - 10479. [Abstract] [Full Text]